Zydus Lifesciences Limited — Others, 20-05-2025: Change in Management

Zydus Lifesciences has announced a board meeting approving the superannuation of CFO Mr. Nitin Parekh, effective August 31, 2025. Parekh played a vital role in strategic areas such as mergers, acquisitions, fund-raising, and cost rationalization. He will be succeeded by Mr. Tushar Shroff, a Chartered Accountant with over 29 years of experience, including 20 years in pharma and prior service at Zydus. Shroff’s expertise in pharma finance, operations, M&A, and investor relations ensures continuity in the company’s financial leadership.